[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100474909":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":58,"centralContacts":63,"locations":73,"responsibleParty":433,"collaborators":435,"id":438,"slug":439,"hasResults":440,"nctId":441,"briefTitle":442,"officialTitle":443,"acronym":11,"eligibilityCriteria":444,"healthyVolunteers":440,"sex":445,"minAge":446,"maxAge":11,"enrollmentInfo":447,"targetDuration":11,"studyType":450,"phases":451,"briefSummary":453,"conditions":454,"keywords":11,"overallStatus":98,"whyStopped":11,"lastUpdateSubmitDate":456,"lastUpdatePostDateStruct":457,"startDateStruct":460,"completionDateStruct":462,"leadSponsor":464,"locationsCount":465},{"fullName":5,"class":6},"EMD Serono","INDUSTRY",[8,14,17,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Part 1: M9140","EXPERIMENTAL",null,[13],"Drug: M9140",{"label":15,"type":10,"description":11,"interventionNames":16},"Part 2A: M9140",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Part 2B: M9140",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"Part 2C: M9140 + Bevacizumab +\u002F-Capecitabine",[13,23,24],"Drug: Bevacizumab","Drug: Capecitabine",{"label":26,"type":10,"description":11,"interventionNames":27},"Part 2D: M9140 + 5-fluorouracil + Folinic acid + Bevacizumab",[13,28,29],"Drug: 5-fluorouracil (5-FU)","Drug: Folinic acid",[31,38,42,46,50,54],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","M9140","M9140 will be administered at an escalated dose until Maximum tolerated dose (MTD) and\u002For a safe recommended Dose for Expansion (RDE) is determined in Part 1 of the study.",[9],[37],"Precemtabart tocentecan",{"type":32,"name":33,"description":39,"armGroupLabels":40,"otherNames":41},"M9140 will be further investigated in part 2 of the study and includes dose optimization, an alternative administration regimen and combination regimen.",[15,18,21,26],[37],{"type":32,"name":43,"description":44,"armGroupLabels":45,"otherNames":11},"Bevacizumab","Bevacizumab will be administered intravenously as per standard of care.",[21],{"type":32,"name":47,"description":48,"armGroupLabels":49,"otherNames":11},"Capecitabine","Capecitabine will be administered orally as per standard of care.",[21],{"type":32,"name":51,"description":52,"armGroupLabels":53,"otherNames":11},"5-fluorouracil (5-FU)","5-FU will be administered intravenously as per standard of care.",[26],{"type":32,"name":55,"description":56,"armGroupLabels":57,"otherNames":11},"Folinic acid","Folinic acid will be administered intravenously as per standard of care.",[26],[59],{"name":60,"affiliation":61,"role":62},"Medical Responsible","EMD Serono Research & Development Institute, Inc.","STUDY_DIRECTOR",[64,69],{"name":65,"role":66,"phone":67,"phoneExt":11,"email":68},"US Medical Information","CONTACT","888-275-7376","eMediUSA@emdserono.com",{"name":70,"role":66,"phone":71,"phoneExt":11,"email":72},"Communication Center","+49 6151 72 5200","service@emdgroup.com",[74,88,96,111,124,136,148,161,172,187,193,199,210,221,227,233,244,256,267,278,289,297,305,313,326,334,342,352,363,374,385,393,401,411,422],{"facility":75,"status":76,"city":77,"state":78,"zip":79,"country":80,"countryCode":81,"cosmosGeoPoint":82,"geoPoint":87,"contacts":11},"California Cancer Associates for Research & Excellence, Inc.","COMPLETED","Encinitas","California","92024","United States","US",{"type":83,"coordinates":84},"Point",[85,86],-117.29198,33.03699,{"lat":86,"lon":85},{"facility":75,"status":76,"city":89,"state":78,"zip":90,"country":80,"countryCode":81,"cosmosGeoPoint":91,"geoPoint":95,"contacts":11},"Fresno","93720",{"type":83,"coordinates":92},[93,94],-119.77237,36.74773,{"lat":94,"lon":93},{"facility":97,"status":98,"city":99,"state":100,"zip":101,"country":80,"countryCode":81,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Rhode Island Hospital","RECRUITING","Providence","Rhode Island","02903",{"type":83,"coordinates":103},[104,105],-71.41283,41.82399,{"lat":105,"lon":104},[108],{"name":109,"role":110,"phone":11,"phoneExt":11,"email":11},"Rimini Breakstone","PRINCIPAL_INVESTIGATOR",{"facility":112,"status":98,"city":113,"state":114,"zip":115,"country":80,"countryCode":81,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Mary Crowley Cancer Research","Dallas","Texas","75230",{"type":83,"coordinates":117},[118,119],-96.80667,32.78306,{"lat":119,"lon":118},[122],{"name":123,"role":110,"phone":11,"phoneExt":11,"email":11},"Minal Barve",{"facility":125,"status":98,"city":126,"state":114,"zip":127,"country":80,"countryCode":81,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"MD Anderson Cancer Center - Oncology","Houston","77030",{"type":83,"coordinates":129},[130,131],-95.36327,29.76328,{"lat":131,"lon":130},[134],{"name":135,"role":110,"phone":11,"phoneExt":11,"email":11},"Kanwal Raghav",{"facility":137,"status":98,"city":138,"state":114,"zip":139,"country":80,"countryCode":81,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"NEXT Oncology","San Antonio","78229",{"type":83,"coordinates":141},[142,143],-98.49363,29.42412,{"lat":143,"lon":142},[146],{"name":147,"role":110,"phone":11,"phoneExt":11,"email":11},"Ismael Rodriguez",{"facility":149,"status":98,"city":150,"state":11,"zip":11,"country":151,"countryCode":152,"cosmosGeoPoint":153,"geoPoint":157,"contacts":158},"The Ottawa Hospital Cancer Centre","Ottawa","Canada","CA",{"type":83,"coordinates":154},[155,156],-75.69812,45.41117,{"lat":156,"lon":155},[159],{"name":160,"role":110,"phone":11,"phoneExt":11,"email":11},"Derek Jonker",{"facility":162,"status":98,"city":163,"state":11,"zip":11,"country":151,"countryCode":152,"cosmosGeoPoint":164,"geoPoint":168,"contacts":169},"University Health Network - Princess Margaret Cancer Centre","Toronto",{"type":83,"coordinates":165},[166,167],-79.39864,43.70643,{"lat":167,"lon":166},[170],{"name":171,"role":110,"phone":11,"phoneExt":11,"email":11},"Abdulazeez Salawu",{"facility":173,"status":98,"city":174,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"National Cancer Center Hospital - Dept of Gastroenterology","Chūōku","Japan","JP",{"type":83,"coordinates":178},[179,180],130.67068,33.63867,{"lat":180,"lon":179},[183,185],{"name":11,"role":66,"phone":11,"phoneExt":11,"email":184},"kenkato@ncc.go.jp",{"name":186,"role":110,"phone":11,"phoneExt":11,"email":11},"Ken Kato",{"facility":188,"status":98,"city":189,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":11,"geoPoint":11,"contacts":190},"National Cancer Center Hospital East","Kashiwa-shi",[191],{"name":192,"role":110,"phone":11,"phoneExt":11,"email":11},"Akihito Kawazoe",{"facility":194,"status":98,"city":195,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":11,"geoPoint":11,"contacts":196},"Saitama Cancer Center","Kitaadachi-gun",[197],{"name":198,"role":110,"phone":11,"phoneExt":11,"email":11},"Hiroki Hara",{"facility":200,"status":98,"city":201,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":202,"geoPoint":206,"contacts":207},"Cancer Institute Hospital of JFCR","Kōtoku",{"type":83,"coordinates":203},[204,205],143.14297,42.50417,{"lat":205,"lon":204},[208],{"name":209,"role":110,"phone":11,"phoneExt":11,"email":11},"Kensei Yamaguchi",{"facility":211,"status":98,"city":212,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":213,"geoPoint":217,"contacts":218},"Aichi Cancer Center Hospital","Nagoya",{"type":83,"coordinates":214},[215,216],136.90641,35.18147,{"lat":216,"lon":215},[219],{"name":220,"role":110,"phone":11,"phoneExt":11,"email":11},"Toshiki Masuishi",{"facility":222,"status":98,"city":223,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":11,"geoPoint":11,"contacts":224},"Kindai University Hospital","Osakasayama-shi",[225],{"name":226,"role":110,"phone":11,"phoneExt":11,"email":11},"Chiaki Inagaki",{"facility":228,"status":98,"city":229,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":11,"geoPoint":11,"contacts":230},"Shizuoka Cancer Center","Sunto-gun",[231],{"name":232,"role":110,"phone":11,"phoneExt":11,"email":11},"Kentaro Yamazaki",{"facility":234,"status":98,"city":235,"state":11,"zip":11,"country":175,"countryCode":176,"cosmosGeoPoint":236,"geoPoint":240,"contacts":241},"Kanagawa Cancer Center","Yokohama",{"type":83,"coordinates":237},[238,239],139.65,35.43333,{"lat":239,"lon":238},[242],{"name":243,"role":110,"phone":11,"phoneExt":11,"email":11},"Nozomu Machida",{"facility":245,"status":98,"city":246,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":248,"geoPoint":252,"contacts":253},"Kyungpook National University Chilgok Hospital","Daegu","South Korea",{"type":83,"coordinates":249},[250,251],128.59111,35.87028,{"lat":251,"lon":250},[254],{"name":255,"role":110,"phone":11,"phoneExt":11,"email":11},"Jong Gwang Kim",{"facility":257,"status":98,"city":258,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":259,"geoPoint":263,"contacts":264},"National Cancer Center","Goyang-si",{"type":83,"coordinates":260},[261,262],126.835,37.65639,{"lat":262,"lon":261},[265],{"name":266,"role":110,"phone":11,"phoneExt":11,"email":11},"Moon Ki Choi",{"facility":268,"status":98,"city":269,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":270,"geoPoint":274,"contacts":275},"Seoul National University Bundang Hospital","Seongnam",{"type":83,"coordinates":271},[272,273],127.7548,36.4052,{"lat":273,"lon":272},[276],{"name":277,"role":110,"phone":11,"phoneExt":11,"email":11},"Keun-Wook Lee",{"facility":279,"status":98,"city":280,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":281,"geoPoint":285,"contacts":286},"Asan Medical Center","Seoul",{"type":83,"coordinates":282},[283,284],126.9784,37.566,{"lat":284,"lon":283},[287],{"name":288,"role":110,"phone":11,"phoneExt":11,"email":11},"Jeong Eun Kim",{"facility":290,"status":98,"city":280,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":291,"geoPoint":293,"contacts":294},"Samsung Medical Center",{"type":83,"coordinates":292},[283,284],{"lat":284,"lon":283},[295],{"name":296,"role":110,"phone":11,"phoneExt":11,"email":11},"Seung Tae Kim",{"facility":298,"status":98,"city":280,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":299,"geoPoint":301,"contacts":302},"Seoul National University Hospital",{"type":83,"coordinates":300},[283,284],{"lat":284,"lon":283},[303],{"name":304,"role":110,"phone":11,"phoneExt":11,"email":11},"Sae-Won Han",{"facility":306,"status":98,"city":280,"state":11,"zip":11,"country":247,"countryCode":11,"cosmosGeoPoint":307,"geoPoint":309,"contacts":310},"Severance Hospital, Yonsei University Health System",{"type":83,"coordinates":308},[283,284],{"lat":284,"lon":283},[311],{"name":312,"role":110,"phone":11,"phoneExt":11,"email":11},"Seung Hoon Beom",{"facility":314,"status":98,"city":315,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":318,"geoPoint":322,"contacts":323},"Hospital Clinic de Barcelona","Barcelona","Spain","ES",{"type":83,"coordinates":319},[320,321],2.15899,41.38879,{"lat":321,"lon":320},[324],{"name":325,"role":110,"phone":11,"phoneExt":11,"email":11},"Joan Maurel Santasusana",{"facility":327,"status":98,"city":315,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":328,"geoPoint":330,"contacts":331},"Hospital del Mar",{"type":83,"coordinates":329},[320,321],{"lat":321,"lon":320},[332],{"name":333,"role":110,"phone":11,"phoneExt":11,"email":11},"Joana Vidal Barrull",{"facility":335,"status":98,"city":315,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":336,"geoPoint":338,"contacts":339},"Hospital HM Nou Delfos",{"type":83,"coordinates":337},[320,321],{"lat":321,"lon":320},[340],{"name":341,"role":110,"phone":11,"phoneExt":11,"email":11},"Tatiana Hernandez Guerrero",{"facility":343,"status":98,"city":315,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":344,"geoPoint":346,"contacts":347},"Hospital Universitari Vall d'Hebron - VHIR",{"type":83,"coordinates":345},[320,321],{"lat":321,"lon":320},[348,350],{"name":11,"role":66,"phone":11,"phoneExt":11,"email":349},"egarralda@vhio.net",{"name":351,"role":110,"phone":11,"phoneExt":11,"email":11},"Elena Garralda Cabanas",{"facility":353,"status":98,"city":354,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":355,"geoPoint":359,"contacts":360},"Hospital Universitario Reina Sofia","Córdoba",{"type":83,"coordinates":356},[357,358],-4.77275,37.89155,{"lat":358,"lon":357},[361],{"name":362,"role":110,"phone":11,"phoneExt":11,"email":11},"Rosa Maria Rodriguez Alonso",{"facility":364,"status":98,"city":365,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":366,"geoPoint":370,"contacts":371},"ICO l'Hospitalet - Hospital Duran i Reynals","L'Hospitalet de Llobregat",{"type":83,"coordinates":367},[368,369],2.10028,41.35967,{"lat":369,"lon":368},[372],{"name":373,"role":110,"phone":11,"phoneExt":11,"email":11},"Jose Carlos Ruffinelli Rodriguez",{"facility":375,"status":98,"city":376,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":377,"geoPoint":381,"contacts":382},"Centro Integral Oncologico Clara Campal","Madrid",{"type":83,"coordinates":378},[379,380],-3.70256,40.4165,{"lat":380,"lon":379},[383],{"name":384,"role":110,"phone":11,"phoneExt":11,"email":11},"Maria Jose de Miguel Luken",{"facility":386,"status":98,"city":376,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":387,"geoPoint":389,"contacts":390},"Hospital Universitario 12 de Octubre",{"type":83,"coordinates":388},[379,380],{"lat":380,"lon":379},[391],{"name":392,"role":110,"phone":11,"phoneExt":11,"email":11},"Rocio Garcia Carbonero",{"facility":394,"status":98,"city":376,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":395,"geoPoint":397,"contacts":398},"Hospital Universitario Fundacion Jimenez Diaz",{"type":83,"coordinates":396},[379,380],{"lat":380,"lon":379},[399],{"name":400,"role":110,"phone":11,"phoneExt":11,"email":11},"Bernard Gaston Doger de Speville Uribe",{"facility":402,"status":98,"city":376,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":403,"geoPoint":405,"contacts":406},"Hospital Universitario Quironsalud Madrid - NEXT Oncology",{"type":83,"coordinates":404},[379,380],{"lat":380,"lon":379},[407,409],{"name":11,"role":66,"phone":11,"phoneExt":11,"email":408},"vboni@nextoncology.eu",{"name":410,"role":110,"phone":11,"phoneExt":11,"email":11},"Valentina Boni",{"facility":412,"status":98,"city":413,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":414,"geoPoint":418,"contacts":419},"Complejo Hospitalario Universitario de Santiago","Santiago de Compostela",{"type":83,"coordinates":415},[416,417],-8.54569,42.88052,{"lat":417,"lon":416},[420],{"name":421,"role":110,"phone":11,"phoneExt":11,"email":11},"Rafael Lopez Lopez",{"facility":423,"status":98,"city":424,"state":11,"zip":11,"country":316,"countryCode":317,"cosmosGeoPoint":425,"geoPoint":429,"contacts":430},"Hospital Universitario Virgen del Rocio","Seville",{"type":83,"coordinates":426},[427,428],-5.97317,37.38283,{"lat":428,"lon":427},[431],{"name":432,"role":110,"phone":11,"phoneExt":11,"email":11},"Manuel Valladares Ayerbes",{"type":434,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[436],{"name":437,"class":6},"Merck KGaA, Darmstadt, Germany","100474909","phase-1-anti-ceacam5-adc-m9140-in-advanced-solid-tumors-proceade-crc-01-100474909",false,"NCT05464030","Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)","A Phase I, Multicenter, Open-Label First in Human Study of Anti-CEACAM5 Antibody Drug Conjugate M9140 in Participants With Advanced Solid Tumors (PROCEADE-CRC-01)","Inclusion Criteria:\n\n* Participants with documented histopathological diagnosis of locally advanced or metastatic colorectal cancer (CRC), who were intolerant\u002Frefractory to or progressed after standard systemic therapies for the advanced\u002Fmetastatic stage, if locally indicated and available to the participant. Participants with a known microsatellite instability high (MSI-H) status must have received treatment with an immune checkpoint inhibitor (if locally indicated and available) unless contraindicated.\n* Eastern Cooperative Oncology Group Performance Status (ECOG PS) below or equal to 1\n* Participants with adequate hematologic, hepatic and renal function as defined in protocol\n* Other protocol defined inclusion criteria could apply\n\nExclusion Criteria:\n\n* Participant has a history of malignancy within 3 years before the date of enrollment (exceptions are squamous and basal cell carcinomas of the skin and carcinoma in situ of the cervix, benign prostate neoplasm\u002Fhypertropia, or malignancy that in the opinion of the Investigator, with concurrence with the Sponsor's Medical Monitor, is considered cured with minimal risk of recurrence within 3 years)\n* Participants with known brain metastases, except those meeting the following criteria: Brain metastases that have been treated locally and are clinically stable for at least 4 weeks prior to the start of treatment; No ongoing neurological symptoms that are related to the brain localization of the disease (sequelae that are a consequence of the treatment of the brain metastases are acceptable)\n* Participants with diarrhea (liquid stool) or ileus Grade \\> 1\n* Participants with active chronic inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease, intestinal perforation) and\u002For bowel obstruction\n* Unstable angina, myocardial infarction, congestive heart failure (New York Heart Association \\[NYHA\\] \\>= II) or a coronary revascularization procedure within 180 days of study entry. Calculated QTc average (using the Fridericia correction calculation) of \\> 470 milliseconds (ms)\n* Cerebrovascular accident\u002Fstroke (\\\u003C 6 months prior to enrollment)\n* Other protocol defined exclusion criteria could apply","ALL","18 Years",{"count":448,"type":449},200,"ESTIMATED","INTERVENTIONAL",[452],"PHASE1","The purpose of this first in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary clinical activity of M9140 in advanced solid tumors. This study contains 2 parts: Dose escalation (Part 1) and dose expansion (Part 2)\n\nStudy details include:\n\n* Study Duration per participant: Approximately 4 months for Part 1 and 8 months for Part 2\n* M9140 is not available through an expanded access program",[455],"Colorectal Cancer","2026-07-01",{"date":458,"type":459},"2026-07-02","ACTUAL",{"date":461,"type":459},"2022-08-04",{"date":463,"type":449},"2026-10-23",{"name":61,"class":6},35]